P.Y. Yu
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
Papers in
-
- Epigenetics and DNA Methylation 2
- Histone Deacetylase Inhibitors Research 2
- FOXO transcription factor regulation 1
- Oncology 4
- Peptidase Inhibition and Analysis 2
- Co-authors
- Jiajie Zhang (7 shared papers)Zhengguang Zhu (5 shared papers)Yuanxin Tian (5 shared papers)Hong Jin (5 shared papers)Dong-Mei Meng (5 shared papers)Yuwen He (4 shared papers)Hui Xie (3 shared papers)Shunjun Jiang (3 shared papers)
In The Last Decade
P.Y. Yu
18 papers receiving 421 citations
Peers
Comparison fields: 5 of 94
- Toxicology 28
- Drug Discovery 1
- Pharmacology 45
- Complementary and alternative medicine 39
- Cancer Research 52
Countries citing papers authored by P.Y. Yu
This map shows the geographic impact of P.Y. Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.Y. Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.Y. Yu more than expected).
Fields of papers citing papers by P.Y. Yu
This network shows the impact of papers produced by P.Y. Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.Y. Yu. The network helps show where P.Y. Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside P.Y. Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 58 | |
| 2 | 2016 | 52 | |
| 3 | 2017 | 49 | |
| 4 | 2015 | 47 | |
| 5 | 2013 | 47 | |
| 6 | 2012 | 33 | |
| 7 | 2013 | 33 | |
| 8 | 2020 | 26 | |
| 9 | 2018 | 24 | |
| 10 | 2017 | 14 | |
| 11 | 2011 | 14 | |
| 12 | 2016 | 11 | |
| 13 | 2020 | 9 | |
| 14 | 2022 | 8 | |
| 15 | Aeromagnetic Data Preprocessing Method Based on Deep Learning | 2019 | 2 |
| 16 | 2022 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2024 | 1 | |
| 19 | 2021 | 0 |
About P.Y. Yu
P.Y. Yu is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Toxicology and Immunology, having authored 19 papers that have together received 431 indexed citations. Recurring topics across this work include Immune Response and Inflammation (3 papers), Epigenetics and DNA Methylation (2 papers), Bioactive Compounds and Antitumor Agents (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Peptidase Inhibition and Analysis (2 papers), Inertial Sensor and Navigation (1 paper), Respiratory Support and Mechanisms (1 paper) and FOXO transcription factor regulation (1 paper). The work is most often cited by research in Toxicology (28 citations), Drug Discovery (1 citation), Pharmacology (45 citations), Complementary and alternative medicine (39 citations) and Cancer Research (52 citations). P.Y. Yu has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Jiajie Zhang, Zhengguang Zhu, Yuanxin Tian, Hong Jin, Dong-Mei Meng, Yuwen He, Hui Xie, Shunjun Jiang, Shanhe Wan and Jing‐Rong Li. Their work appears in journals such as Frontiers in Pharmacology, European Journal of Medicinal Chemistry, Biological Chemistry, Molecular Therapy — Oncolytics and Pharmaceutical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.